Kore Private Wealth LLC Biomarin Pharmaceutical Inc Transaction History

Kore Private Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $4,312 - $7,861	-60 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $3,659 - $5,714	46 Added 328.57%	60 $7,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $899 - $1,209	14 New	14 $1,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $2,169 - $2,535	-27 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$84.2 - $98.62 $1,684 - $1,972	-20 Reduced 42.55%	27 $2,000
Q4 2018 May 23, 2019	BUY	$80.14 - $106.07 $3,766 - $4,985	47 New	47 $4,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.